References
- Aiello I, Fedele MLM, Roman F, Marpegan L, Caldart C, Chiesa JJ, Golombek DA, Finkielstein CV, Paladino N. 2020. Circadian disruption promotes tumor-immune microenvironment remodeling favoring tumor cell proliferation. Sci Adv. 6. doi:https://doi.org/10.1126/sciadv.aaz4530.
- Altman BJ, Hsieh AL, Gouw AM, Dang CV. 2017. Correspondence: oncogenic MYC persistently upregulates the molecular clock component REV-ERBalpha. Nat Commun. 8:14862. doi:https://doi.org/10.1038/ncomms14862.
- Altman BJ, Hsieh AL, Sengupta A, Krishnanaiah SY, Stine ZE, Walton ZE, Gouw AM, Venkataraman A, Li B, Goraksha-Hicks P, et al. 2015. MYC disrupts the circadian clock and metabolism in cancer cells. Cell Metab. 22:1009–1019. doi:https://doi.org/10.1016/j.cmet.2015.09.003.
- Al-Zoughbi W, Huang J, Paramasivan GS, Till H, Pichler M, Guertl-Lackner B, Hoefler G. 2014. Tumor macroenvironment and metabolism. Semin Oncol. 41:281–295. doi:https://doi.org/10.1053/j.seminoncol.2014.02.005.
- Angelousi A, Kassi E, Ansari-Nasiri N, Randeva H, Kaltsas G, Chrousos G. 2019. Clock genes and cancer development in particular in endocrine tissues. Endocr Relat Cancer. 26:R305–R317. doi:https://doi.org/10.1530/ERC-19-0094.
- Azpiroz A, De Miguel Z, Fano E, Vegas O. 2008. Relations between different coping strategies for social stress, tumor development and neuroendocrine and immune activity in male mice. Brain Behav Immun. 22:690–698. doi:https://doi.org/10.1016/j.bbi.2007.10.007.
- Bonaconsa M, Malpeli G, Montaruli A, Carandente F, Grassi-Zucconi G, Bentivoglio M. 2014. Differential modulation of clock gene expression in the suprachiasmatic nucleus, liver and heart of aged mice. Exp Gerontol. 55:70–79. doi:https://doi.org/10.1016/j.exger.2014.03.011.
- Bulbul Y, Ozlu T, Arinc S, Akinci Ozyurek B, Gunbatar H, Senturk A, Bahadir A, Ozcelik M, Yilmaz U, Akbay MO, et al. 2018. Sleep disturbances in patients with lung cancer in Turkey. Tuberk Toraks. 66:297–303. doi:https://doi.org/10.5578/tt.67689.
- Bunger MK, Wilsbacher LD, Moran SM, Clendenin C, Radcliffe LA, Hogenesch JB, Simon MC, Takahashi JS, Bradfield CA. 2000. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell. 103:1009–1017. doi:https://doi.org/10.1016/s0092-8674(0000205-1).
- Chang Y, Zhao C, Ding H, Wang T, Yang C, Nie X, Cai Y. 2021. Serum factor(s) from lung adenocarcinoma patients regulates the molecular clock expression. J Cancer Res Clin Oncol. 147:493–498. doi:https://doi.org/10.1007/s00432-020-03467-5.
- Chen HM, Wu YC, Tsai CM, Tzeng JI, Lin CC. 2015. Relationships of circadian rhythms and physical activity with objective sleep parameters in lung cancer patients. Cancer Nurs. 38:215–223. doi:https://doi.org/10.1097/NCC.0000000000000163.
- Chen Z, Yoo SH, Takahashi JS. 2018. Development and therapeutic potential of small-molecule modulators of circadian systems. Annu Rev Pharmacol Toxicol. 58:231–252. doi:https://doi.org/10.1146/annurev-pharmtox-010617-052645.
- D’Mello C, Swain MG. 2017. Immune-to-brain communication pathways in inflammation-associated sickness and depression. Curr Top Behav Neurosci. 31:73–94. doi:https://doi.org/10.1007/7854_2016_37.
- de Assis LVM, Moraes MN, Magalhaes-Marques KK, Kinker GS, da Silveira Cruz-Machado S, Castrucci AML. 2018. Non-metastatic cutaneous melanoma induces chronodisruption in central and peripheral circadian clocks. Int J Mol Sci. 19. doi:https://doi.org/10.3390/ijms19041065.
- Du YJ, Zhang HY, Li B, Wu X, Lv YB, Jin HL, Cao YX, Sun J, Luo QL, Gong WY, et al. 2013. Sputum interleukin-6, tumor necrosis factor-alpha and Salivary cortisol as new biomarkers of depression in lung cancer patients. Prog Neuropsychopharmacol Biol Psychiatry. 47:69–76. doi:https://doi.org/10.1016/j.pnpbp.2013.08.004.
- Duhart JM, Brocardo L, Mul Fedele ML, Guglielmotti A, Golombek DA. 2016. CCL2 mediates the circadian response to low dose endotoxin. Neuropharmacology. 108:373–381. doi:https://doi.org/10.1016/j.neuropharm.2016.05.005.
- Filipski E, Delaunay F, King VM, Wu MW, Claustrat B, Grechez-Cassiau A, Guettier C, Hastings MH, Francis L. 2004. Effects of chronic jet lag on tumor progression in mice. Cancer Res. 64:7879–7885. doi:https://doi.org/10.1158/0008-5472.CAN-04-0674.
- Gadek-Michalska A, Tadeusz J, Rachwalska P, Bugajski J. 2013. Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems. Pharmacol Reports. 65:1655–1662. doi:https://doi.org/10.1016/s1734-1140(13)71527-5.
- Golombek DA, Casiraghi LP, Agostino PV, Paladino N, Duhart JM, Plano SA, Chiesa JJ. 2013. The times they’re a-changing: effects of circadian desynchronization on physiology and disease. J Physiol Paris. 107:310–322. doi:https://doi.org/10.1016/j.jphysparis.2013.03.007.
- Gong S, Miao YL, Jiao GZ, Sun MJ, Li H, Lin J, Luo MJ, Tan JH. 2015. Dynamics and correlation of serum cortisol and corticosterone under different physiological or stressful conditions in mice. PloS One. 10:e0117503. doi:https://doi.org/10.1371/journal.pone.0117503.
- Halle IH, Westgaard TK, Wahba A, Oksholm T, Rustoen T, Gjeilo KH. 2017. Trajectory of sleep disturbances in patients undergoing lung cancer surgery: a prospective study. Interact Cardiovasc Thorac Surg. 25:285–291. doi:https://doi.org/10.1093/icvts/ivx076.
- Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M. 2010. It’s not over when it’s over: long-term symptoms in cancer survivors–a systematic review. Int J Psychiatry Med. 40:163–181. doi:https://doi.org/10.2190/PM.40.2.c.
- Hojo H, Enya S, Arai M, Suzuki Y, Nojiri T, Kangawa K, Koyama S, Kawaoka S. 2017. Remote reprogramming of hepatic circadian transcriptome by breast cancer. Oncotarget. 8:34128–34140. doi:https://doi.org/10.18632/oncotarget.16699.
- Innominato PF, Focan C, Gorlia T, Moreau T, Garufi C, Waterhouse J, Giacchetti S, Coudert B, Iacobelli S, Genet D, et al. 2009. Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res. 69:4700–4707. doi:https://doi.org/10.1158/0008-5472.CAN-08-4747.
- Ji RR, Chasalow SD, Wang L, Hamid O, Schmidt H, Cogswell J, Alaparthy S, Berman D, Jure-Kunkel M, Siemers NO, et al. 2012. An immune-active tumor microenvironment favors clinical response to ipilimumab. Cancer Immunol Immuno. 61:1019–1031. doi:https://doi.org/10.1007/s00262-011-1172-6.
- Kiessling S, Beaulieu-Laroche L, Blum ID, Landgraf D, Welsh DK, Storch KF, Labrecque N, Cermakian N. 2017a. Enhancing circadian clock function in cancer cells inhibits tumor growth. BMC Biol. 15:13. doi:https://doi.org/10.1186/s12915-017-0349-7.
- Kiessling S, Cermakian N. 2017b. The tumor circadian clock: a new target for cancer therapy. Future Oncol. 13:2607–2610. doi:https://doi.org/10.2217/fon-2017-0456.
- Kim KS, Kim YC, Oh IJ, Kim SS, Choi JY, Ahn RS. 2012. Association of worse prognosis with an aberrant diurnal cortisol rhythm in patients with advanced lung cancer. Chronobiol Int. 29:1109–1120. doi:https://doi.org/10.3109/07420528.2012.706767.
- Lee BN, Dantzer R, Langley KE, Bennett GJ, Dougherty PM, Dunn AJ, Meyers CA, Miller AH, Payne R, Reuben JM, et al. 2004. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation. 11:279–292. doi:https://doi.org/10.1159/000079408.
- Lee S, Donehower LA, Herron AJ, Moore DD, Fu L. 2010. Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PloS One. 5:e10995. doi:https://doi.org/10.1371/journal.pone.0010995.
- Lee YM, Chang WC, Ma WL. 2016. Hypothesis: solid tumours behave as systemic metabolic dictators. J Cell Mol Med. 20:1076–1085. doi:https://doi.org/10.1111/jcmm.12794.
- Lissoni P, Brivio F, Fumagalli L, Messina G, Vigore L, Parolini D, Colciago M, Rovelli F. 2008a. Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors. Anticancer Res. 28:1377–1381.
- Lissoni P, Messina G, Balestra A, Colciago M, Brivio F, Fumagalli L, Fumagalli G, Parolini D. 2008b. Efficacy of cancer chemotherapy in relation to synchronization of cortisol rhythm, immune status and psychospiritual profile in metastatic non-small cell lung cancer. In Vivo (Brooklyn). 22:257–262.
- Liu AC, Welsh DK, Ko CH, Tran HG, Zhang EE, Priest AA, Buhr ED, Singer O, Meeker K, Verma IM, et al. 2007. Intercellular coupling confers robustness against mutations in the SCN circadian clock network. Cell. 129:605–616. doi:https://doi.org/10.1016/j.cell.2007.02.047.
- Lu H, Chu Q, Xie G, Han H, Chen Z, Xu B, Yue Z. 2015. Circadian gene expression predicts patient response to neoadjuvant chemoradiation therapy for rectal cancer. Int J Clin Exp Pathol. 8:10985–10994.
- Lu Y, Zheng X, Hu W, Bian S, Zhang Z, Tao D, Liu Y, Ma Y. 2017. Cancer/testis antigen PIWIL2 suppresses circadian rhythms by regulating the stability and activity of BMAL1 and CLOCK. Oncotarget. 8:54913–54924. doi:https://doi.org/10.18632/oncotarget.18973.
- Masri S, Papagiannakopoulos T, Kinouchi K, Liu Y, Cervantes M, Baldi P, Jacks T, Sassone-Corsi P. 2016. Lung adenocarcinoma distally rewires hepatic circadian homeostasis. Cell. 165:896–909. doi:https://doi.org/10.1016/j.cell.2016.04.039.
- Masri S, Sassone-Corsi P. 2018. The emerging link between cancer, metabolism, and circadian rhythms. Nat Med. 24:1795–1803. doi:https://doi.org/10.1038/s41591-018-0271-8.
- Matsu-Ura T, Moore SR, Hong CI. 2018. WNT takes two to tango: molecular links between the circadian clock and the cell cycle in adult stem cells. J Biol Rhythms. 33:5–14. doi:https://doi.org/10.1177/0748730417745913.
- Mazzoccoli G, Vendemiale G, De Cata A, Carughi S, Tarquini R. 2010. Altered time structure of neuro-endocrine-immune system function in lung cancer patients. BMC Cancer. 10:314. doi:https://doi.org/10.1186/1471-2407-10-314.
- Miki T, Matsumoto T, Zhao Z, Lee CC. 2013. p53 regulates Period2 expression and the circadian clock. Nat Commun. 4:2444. doi:https://doi.org/10.1038/ncomms3444.
- Monje FJ, Cicvaric A, Acevedo Aguilar JP, Elbau I, Horvath O, Diao W, Glat M, Pollak DD. 2017. Disrupted ultradian activity rhythms and differential expression of several clock genes in Interleukin-6-deficient mice. Front Neurol. 8:99. doi:https://doi.org/10.3389/fneur.2017.00099.
- Mormont MC, Waterhouse J, Bleuzen P, Giacchetti S, Jami A, Bogdan A, Lellouch J, Misset JL, Touitou Y, Levi F. 2000. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res. 6:3038–3045.
- Mteyrek A, Filipski E, Guettier C, Oklejewicz M, van der Horst GT, Okyar A, Levi F. 2017. Critical cholangiocarcinogenesis control by cryptochrome clock genes. Int J Cancer. 140:2473–2483. doi:https://doi.org/10.1002/ijc.30663.
- O’Connor DB, Walker S, Hendrickx H, Talbot D, Schaefer A. 2013. Stress-related thinking predicts the cortisol awakening response and somatic symptoms in healthy adults. Psychoneuroendocrinology. 38:438–446. doi:https://doi.org/10.1016/j.psyneuen.2012.07.004.
- Ode KL, Ukai H, Susaki EA, Narumi R, Matsumoto K, Hara J, Koide N, Abe T, Kanemaki MT, Kiyonari H, et al. 2017. Knockout-rescue embryonic stem cell-derived mouse reveals circadian-period control by quality and quantity of CRY1. Mol Cell. 65:176–190. doi:https://doi.org/10.1016/j.molcel.2016.11.022.
- Paladino N, Mul Fedele ML, Duhart JM, Marpegan L, Golombek DA. 2014. Modulation of mammalian circadian rhythms by tumor necrosis factor-alpha. Chronobiol Int. 31:668–679. doi:https://doi.org/10.3109/07420528.2014.886588.
- Portaluppi F, Smolensky MH, Touitou Y. 2010. Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911–1929. doi:https://doi.org/10.3109/07420528.2010.516381.
- Putker M, Wong DCS, Seinkmane E, Rzechorzek NM, Zeng A, Hoyle NP, Chesham JE, Edwards MD, Feeney KA, Fischer R, et al. 2021. CRYPTOCHROMES confer robustness, not rhythmicity, to circadian timekeeping. EMBO J. e106745. doi:https://doi.org/10.15252/embj.2020106745.
- Qiu M, Chen YB, Jin S, Fang XF, He XX, Xiong ZF, Yang SL. 2019a. Research on circadian clock genes in non-small-cell lung carcinoma. Chronobiol Int. 36:739–750. doi:https://doi.org/10.1080/07420528.2018.1509080.
- Qiu MJ, Liu LP, Jin S, Fang XF, He XX, Xiong ZF, Yang SL. 2019b. Research on circadian clock genes in common abdominal malignant tumors. Chronobiol Int. 36:906–918. doi:https://doi.org/10.1080/07420528.2018.1477792.
- Russell G, Lightman S. 2019. The human stress response. Nat Rev Endocrinol. 15:525–534. doi:https://doi.org/10.1038/s41574-019-0228-0.
- Sahar S, Zocchi L, Kinoshita C, Borrelli E, Sassone-Corsi P. 2010. Regulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation. PloS One. 5:e8561. doi:https://doi.org/10.1371/journal.pone.0008561.
- Shostak A, Diernfellner A, Brunner M. 2016a. MYC inhibits the clock and supports proliferation. Cell Cycle. 15:3323–3324. doi:https://doi.org/10.1080/15384101.2016.1224760.
- Shostak A, Ruppert B, Ha N, Bruns P, Toprak UH, Eils R, Schlesner M, Diernfellner A, Brunner M. 2016b. MYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation. Nat Commun. 7:11807. doi:https://doi.org/10.1038/ncomms11807.
- Sokolove PG, Bushell WN. 1978. The chi square periodogram: its utility for analysis of circadian rhythms. J Theor Biol. 72:131–160. doi:https://doi.org/10.1016/0022-5193(78)90022-x.
- Sullivan KA, Bever SR, McKim DB, Godbout JP, Sheridan JF, Obrietan K, Pyter LM. 2019. Mammary tumors compromise time-of-day differences in hypothalamic gene expression and circadian behavior and physiology in mice. Brain Behav Immun. 80:805–817. doi:https://doi.org/10.1016/j.bbi.2019.05.028.
- Taniguchi H, Fernandez AF, Setien F, Ropero S, Ballestar E, Villanueva A, Yamamoto H, Imai K, Shinomura Y, Esteller M. 2009. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. Cancer Res. 69:8447–8454. doi:https://doi.org/10.1158/0008-5472.CAN-09-0551.
- Valles SL, Benlloch M, Rodriguez ML, Mena S, Pellicer JA, Asensi M, Obrador E, Estrela JM. 2013. Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism. J Transl Med. 11:72. doi:https://doi.org/10.1186/1479-5876-11-72.
- Van Dycke KC, Rodenburg W, van Oostrom CT, van Kerkhof LW, Pennings JL, Roenneberg T, van Steeg H, Van Der Horst GT. 2015. Chronically alternating light cycles increase breast cancer risk in mice. Curr Biolo. 25:1932–1937. doi:https://doi.org/10.1016/j.cub.2015.06.012.
- Vegas O, Garmendia L, Arregi A, Beitia G, Azpiroz A. 2009. Effects of antalarmin and nadolol on the relationship between social stress and pulmonary metastasis development in male OF1 mice. Behav Brain Res. 205:200–206. doi:https://doi.org/10.1016/j.bbr.2009.06.033.
- Vitale JA, Lombardi G, Weydahl A, Banfi G. 2018. Biological rhythms, chronodisruption and chrono-enhancement: the role of physical activity as synchronizer in correcting steroids circadian rhythm in metabolic dysfunctions and cancer. Chronobiol Int. 35:1185–1197. doi:https://doi.org/10.1080/07420528.2018.1475395.
- Vitaterna MH, Selby CP, Todo T, Niwa H, Thompson C, Fruechte EM, Hitomi K, Thresher RJ, Ishikawa T, Miyazaki J, et al. 1999. Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. Proc Natl Acad Sci USA. 96:12114–12119. doi:https://doi.org/10.1073/pnas.96.21.12114.
- Yin L, Wang J, Klein PS, Lazar MA. 2006. Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science. 311:1002–1005. doi:https://doi.org/10.1126/science.1121613.